Clinical Trial Update: A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on WZTL-002 CAR T-cells for adults with relapsed large B-cell lymphoma, including DLBCL and related subtypes, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma
• Transformed Non-hodgkin Lymphoma

Drugs mentioned

• WZTL-002 CAR T-cells

Snippet

Sponsor: Malaghan Institute of Medical Research | Conditions: Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 2 | Status: RECRUITING